VHL Ligand-Linker Conjugates 15
Code | Size | Price |
---|
TAR-T17908-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T17908-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
VHL Ligand-Linker Conjugates 15 is a chemical compound that combines a VHL ligand, which targets the E3 ubiquitin ligase, with a PROTAC linker. It is specifically designed for the creation of PROTACs[1].
CAS:
2375564-62-6
Molecular Weight:
724.84
Purity:
0.98
SMILES:
C([C@@H](NC(=O)C1(F)CC1)C(C)(C)C)(=O)N2[C@H](C(NCC3=C(OCCOC4=CC=C(C=C4)C5OCCO5)C=C(C=C3)C=6SC=NC6C)=O)C[C@@H](O)C2
References
Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.